Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Direct Selling Business	11.03B	10.06B	7.80B	7.51B	6.97B
Direct Selling Business Growth	9.71%	28.96%	3.81%	7.76%	7.62%
Distribution Business	6.74B	5.28B	4.04B	2.47B	1.53B
Distribution Business Growth	27.55%	30.88%	63.26%	62.04%	230.96%
Service Business	112.39M	75.47M	33.24M	24.66M	27.74M
Service Business Growth	48.92%	127.08%	34.75%	-11.07%	953.97%
Total	17.88B	15.41B	11.87B	10.01B	8.52B
Total Growth	16.01%	29.89%	18.57%	17.41%	22.82%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
North China	3.51B	3.03B	2.21B	2.04B	1.83B
North China Growth	15.93%	37.10%	8.41%	11.26%	0.46%
East China	6.37B	5.54B	4.06B	2.88B	2.25B
East China Growth	14.98%	36.43%	40.82%	27.96%	75.06%
Northwest China	1.36B	1.25B	1.06B	1.17B	1.17B
Northwest China Growth	9.27%	17.20%	-9.03%	-0.36%	8.96%
Central China	1.82B	1.46B	1.29B	1.18B	1.14B
Central China Growth	25.12%	13.43%	9.01%	3.06%	16.72%
Southwest China	2.01B	1.53B	1.16B	771.53M	699.66M
Southwest China Growth	30.82%	32.61%	49.81%	10.27%	-1.90%
South China	1.30B	1.33B	1.14B	1.04B	730.49M
South China Growth	-1.91%	15.84%	10.54%	41.76%	22.06%
Northeast China	1.51B	1.28B	947.59M	931.13M	682.76M
Northeast China Growth	17.71%	35.27%	1.77%	36.38%	47.73%
Overseas	-	-	-	478.62K	8.90M
Overseas Growth	-	-	-	-94.62%	-
Total	17.88B	15.41B	11.87B	10.01B	8.52B
Total Growth	16.01%	29.89%	18.57%	17.41%	22.82%

Source: S&P Global Market Intelligence.